©The Author(s) 2025.
World J Clin Oncol. Oct 24, 2025; 16(10): 112392
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.112392
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.112392
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart outlining the literature screening process, study selection, and exclusion criteria.
- Citation: Tom L, Mani S, Rawat A, Nan M, Mundada SM, Al Khatib B, Gopinath A, Taj O, Salahuddin N, Shaju F, Parsa S, Abdurrahman M, Das A, Khawar MMH, Sher A. Ropeginterferon alfa-2b vs standard therapy in polycythemia vera: A meta-analysis of efficacy and safety outcomes. World J Clin Oncol 2025; 16(10): 112392
- URL: https://www.wjgnet.com/2218-4333/full/v16/i10/112392.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i10.112392